Ayman Saad, MD, MSc

Ayman Saad


College of Medicine


Internal Medicine

Academic Title


Research Program

Leukemia Research

Ayman Saad, MD, MSc, is a member of the Leukemia Research Program at the OSUCCC – James, where his research focuses primarily on investigating the clinical application of cellular and immune-based therapies for hematologic diseases.

Dr. Saad’s current research explores strategies to decrease risk of relapse after allogeneic stem cell transplantation for leukemia patients. This includes methods of graft manipulations, in particular utilizing gamma delta T cells. He completed a phase I study of this approach while at the University of Alabama at Birmingham and is collaborating with a biotech company and other U.S. institutions to initiate a first-in-human study using ex vivo-activated expanded gamma delta T-cell boost with haplo-identical allogeneic stem cell transplant in leukemia patients.

In collaboration with national and European transplant registries, he is also investigating the role of allogeneic stem cell transplantation as a curative therapy for erythropoietic protoporphyria, an uncommon hereditary inborn error of metabolism.

Dr. Saad has co-authored numerous articles in peer-reviewed publications such as Cancer, Biology of Blood and Marrow Transplantation, Blood and Journal of the National Comprehensive Cancer Network.


  • Doctorate, Ain Shams Medical School

    Cairo, Egypt (Africa)

  • Doctorate, Ain Shams Medical School

    Cairo, Egypt (Africa)

Office Location

B321 Starling Loving Hall

320 W 10th Ave, Columbus, OH 43210



Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Search for Clinical Trials

Find a Scientific Publication